{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:36:27Z","timestamp":1770744987477,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Significant Projects of New Drugs Creation","award":["2009ZX09102-134"],"award-info":[{"award-number":["2009ZX09102-134"]}]},{"name":"National Significant Projects of New Drugs Creation","award":["2009ZX09502-013"],"award-info":[{"award-number":["2009ZX09502-013"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.cbi.2011.12.001","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T01:56:05Z","timestamp":1323654965000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Induction of cytochrome P450 3A by Shexiang Baoxin Pill and its main components"],"prefix":"10.1016","volume":"195","author":[{"given":"Bo","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouhong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wansheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2011.12.001_b0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1081\/DMR-120001392","article-title":"Summary of information on human CYP enzymes: human P450 metabolism data","volume":"34","author":"Rendic","year":"2002","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.cbi.2011.12.001_b0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1081\/DMR-100102338","article-title":"The human CYP3A subfamily: practical considerations","volume":"32","author":"Wrighton","year":"2000","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.cbi.2011.12.001_b0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cbi.2008.10.054","article-title":"Effects of Andrographis paniculata extract and Andrographolide on hepatic cytochrome P450 mRNA expression and monooxygenase activities after in vivo administration to rats and in vitro in rat and human hepatocyte cultures","volume":"179","author":"Pekthong","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2011.12.001_b0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1211\/0022357991772105","article-title":"Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats","volume":"51","author":"Zhu","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.cbi.2011.12.001_b0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/187231208783478489","article-title":"Induction of cytochrome P450 3A by the Ginkgo biloba extract and bilobalides in human and rat primary hepatocytes","volume":"2","author":"Deng","year":"2008","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.cbi.2011.12.001_b0030","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1124\/dmd.110.035253","article-title":"The Chinese herbal medicine Sophora flavescens activates pregnane X receptor","volume":"38","author":"Wang","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2011.12.001_b0035","first-page":"1077","article-title":"Effect of shexiang baoxin pill on the function of vascular endothelium in patients with diabetes mellitus type 2 complicated with angina pectoris","volume":"24","author":"Ye","year":"2004","journal-title":"Chin. J. Integr. Tradit. West. Med."},{"key":"10.1016\/j.cbi.2011.12.001_b0040","first-page":"204","article-title":"Clinical observation on artificial shexiang baoxin pill in treating 112 patients of coronary heart disease with angina pectoris","volume":"18","author":"Wang","year":"1998","journal-title":"Chin. J. Integr. Tradit. West. Med."},{"key":"10.1016\/j.cbi.2011.12.001_b0045","unstructured":"Chinese Pharmacopoeia Commission, Pharmacopoeia of the People\u2019s Republic of China, Shexiang Baoxin Pills, People\u2019s Medical Publishing House, Beijing, 2005, pp. 624\u2013625."},{"key":"10.1016\/j.cbi.2011.12.001_b0050","first-page":"780","article-title":"Effects of shexiang baoxin pill on carotid atheromatous plaque","volume":"26","author":"Hong","year":"2006","journal-title":"Chin. J. Integr. Tradit. West. Med."},{"key":"10.1016\/j.cbi.2011.12.001_b0055","first-page":"399","article-title":"Evaluation on tolerability and safety of long-term administration with shexiang baoxin pill in patients with coronary heart disease of stable angina pectoris","volume":"28","author":"Wang","year":"2008","journal-title":"Chin. J. Integr. Tradit. West. Med."},{"key":"10.1016\/j.cbi.2011.12.001_b0060","first-page":"972","article-title":"Joint betaloc treatment shexiangbaoxin pill clinical effects of 120 angina pectoris","volume":"11","author":"Wu","year":"2009","journal-title":"Chin. J. Med. Guide."},{"key":"10.1016\/j.cbi.2011.12.001_b0065","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1016\/0006-2952(87)90668-X","article-title":"Induction of cytochrome P-450 and related drug-oxidizing activities in muscone (3-methylcyclopentadecanone)-treated rats","volume":"36","author":"Tanaka","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2011.12.001_b0070","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0006-2952(91)90551-F","article-title":"Characterization of liver microsomal cytochrome P450 from rats treated with muscone (3-methylcyclopentadecanone)","volume":"41","author":"Tanaka","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2011.12.001_b0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.cbi.2011.12.001_b0080","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1124\/dmd.31.8.1035","article-title":"Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties","volume":"31","author":"Wilkening","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2011.12.001_b0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2011.12.001_b0090","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.phrs.2008.01.006","article-title":"ABC transporters and the accumulation of imatinib and its active metabolite CGP74588 in rat C6 glioma cells","volume":"57","author":"Decleves","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2011.12.001_b0095","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1124\/dmd.105.008185","article-title":"Cytochrome P450 gene induction in rats ex vivo assessed by quantitative real-time reverse transcriptase-polymerase chain reaction (TaqMan)","volume":"34","author":"Baldwin","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2011.12.001_b0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jchromb.2007.09.026","article-title":"Simultaneous determination of five main active bufadienolides of Chan Su in rat plasma by liquid chromatography tandem mass spectrometry","volume":"859","author":"Xu","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.cbi.2011.12.001_b0105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.cbi.2011.12.001_b0110","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.1016\/S0021-9258(17)39626-6","article-title":"Complete cDNA and protein sequence of a pregnenolone 16 alpha-carbonitrile-induced cytochrome P-450. A representative of a new gene family","volume":"260","author":"Gonzalez","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2011.12.001_b0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ypmed.2009.05.003","article-title":"Complementary\/alternative medicine in the context of prevention of disease and maintenance of health","volume":"49","author":"Kraft","year":"2009","journal-title":"Prev. Med."},{"key":"10.1016\/j.cbi.2011.12.001_b0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00045391-200305000-00003","article-title":"Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals","volume":"10","author":"Brazier","year":"2003","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.cbi.2011.12.001_b0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archinte.165.3.281","article-title":"Recent trends in use of herbal and other natural products","volume":"165","author":"Kelly","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cbi.2011.12.001_b0130","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1124\/dmd.107.019612","article-title":"Identification and characterization of potent CYP2B6 inhibitors in Woohwangcheongsimwon suspension, an herbal preparation used in the treatment and prevention of apoplexy in Korea and China","volume":"36","author":"Kim","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2011.12.001_b0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/03602530601093489","article-title":"Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies","volume":"39","author":"Hewitt","year":"2007","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.cbi.2011.12.001_b0140","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0041-008X(03)00128-5","article-title":"An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons","volume":"189","author":"Brandon","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2011.12.001_b0145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00204-008-0332-8","article-title":"Inhibition and induction of human cytochrome P450 enzymes: current status","volume":"82","author":"Pelkonen","year":"2008","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2011.12.001_b0150","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.tiv.2007.05.014","article-title":"Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells","volume":"21","author":"Westerink","year":"2007","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.cbi.2011.12.001_b0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0024-3205(03)00262-5","article-title":"Induction of CYP3A4 by 1alpha, 25-dyhydroxyvitamin D3 in HepG2 cells","volume":"73","author":"Elizondo","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2011.12.001_b0160","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1248\/bpb.26.510","article-title":"Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor","volume":"26","author":"Usui","year":"2003","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.cbi.2011.12.001_b0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.toxlet.2005.01.003","article-title":"Transcriptional induction of CYP3A4 by o, p\u2032-DDT in HepG2 cells","volume":"157","author":"Medina-Diaz","year":"2005","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2011.12.001_b0170","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/138920006776873535","article-title":"Evaluation of 170 xenobiotics as transactivators of human pregnane X receptor (hPXR) and correlation to known CYP3A4 drug interactions","volume":"7","author":"Sinz","year":"2006","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.cbi.2011.12.001_b0175","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s11095-008-9788-8","article-title":"Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways","volume":"26","author":"Li","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.cbi.2011.12.001_b0180","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/00498250310001657568","article-title":"Phase I and II enzyme characterization of two sources of HepG2 cell lines","volume":"34","author":"Hewitt","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2011.12.001_b0185","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1124\/jpet.103.061671","article-title":"Isolation and characterization of a new major intestinal CYP3A form, CYP3A62, in the rat","volume":"309","author":"Matsubara","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2011.12.001_b0190","series-title":"Cytochrome P450: Structure, Function and Mechanism","author":"Lewis","year":"1996"},{"key":"10.1016\/j.cbi.2011.12.001_b0195","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1124\/dmd.31.6.776","article-title":"Effects of acute renal failure on the pharmacokinetics of chlorzoxazone in rats","volume":"31","author":"Moon","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2011.12.001_b0200","unstructured":"Food and Drug Administration\/Center for Drug Evaluation and Research (FDA\/CDER), Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers, Rockville, MD, 2005, pp. 6\u20139."},{"key":"10.1016\/j.cbi.2011.12.001_b0205","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1248\/cpb.54.1058","article-title":"Chemical fingerprinting of Shexiang Baoxin Pill and simultaneous determination of its major constituents by HPLC with evaporative light scattering detection and electrospray mass spectrometric detection","volume":"54","author":"Yan","year":"2006","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.cbi.2011.12.001_b0210","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/bmc.1258","article-title":"Analysis of the constituents in rat plasma after oral administration of Shexiang Baoxin pill by HPLC\u2013ESI-MS\/MS","volume":"23","author":"Jiang","year":"2009","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.cbi.2011.12.001_b0215","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jpba.2010.05.009","article-title":"Analysis of the bioactive constituents of ChanSu in rat plasma by high performance liquid chromatography with mass spectrometric detection","volume":"53","author":"Xia","year":"2010","journal-title":"J. Pharm. Biomed."},{"key":"10.1016\/j.cbi.2011.12.001_b0220","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0006-2952(86)90287-X","article-title":"Induction of rat liver microsomal cytochrome P-450 by muscone (3-methylcyclopentadecanone)","volume":"35","author":"Peng","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2011.12.001_b0225","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/aps.2009.42","article-title":"Bufalin inhibits CYP3A4 activity in vitro and in vivo","volume":"30","author":"Li","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cbi.2011.12.001_b0230","first-page":"750","article-title":"In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam","volume":"25","author":"Nims","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2011.12.001_b0235","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1124\/dmd.31.4.439","article-title":"Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition","volume":"31","author":"Sahi","year":"2003","journal-title":"Drug Metab. Dispos."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279711003309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279711003309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:26:43Z","timestamp":1757856403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279711003309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0009279711003309"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2011.12.001","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of cytochrome P450 3A by Shexiang Baoxin Pill and its main components","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2011.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}